WeVote
Log In

Bill

Bill

AB 554

Health care coverage: antiretroviral drugs, drug devices, and drug products.

2025-2026 Regular Session Introduced by Mark González and 5 co-sponsors

AB 554 required California insurers to cover HIV antiretroviral drugs and devices with zero cost-sharing, but was vetoed by the Governor in October 2025.

Consideration of Governor's veto stricken from file.
#healthcarecoverage #antiretroviraldrugs #drugdevices #anddrugproducts
0
WeVote Research Nonpartisan
Bill Summary · AB 554

Legislative bill overview

AB 554 would have required California health insurance plans to cover antiretroviral drugs, devices, and related products for HIV prevention and treatment without cost-sharing (copayments, coinsurance, or deductibles). The bill aimed to remove financial barriers to HIV medications by mandating zero-cost access through both private and public health insurance plans.

Why is this important

HIV treatment and prevention medications like PrEP (pre-exposure prophylaxis) and antiretroviral therapy are expensive but highly effective at preventing transmission and maintaining health. Removing cost barriers increases medication adherence and access, particularly for lower-income individuals who might otherwise skip doses or forego treatment due to cost. This has public health implications for reducing HIV transmission rates.

Potential points of contention

  • Insurance premium costs: Requiring zero-cost coverage of expensive medications without cost-sharing may increase overall health insurance premiums for all enrollees, shifting costs across the insurance pool
  • Scope of coverage: Defining which specific drugs, devices, and products qualify as necessary antiretroviral treatments versus optional or experimental therapies could be contentious
  • State budget impact: Medi-Cal (California's Medicaid program) coverage requirements directly affect state spending, which may have influenced the Governor's veto decision

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.